A recent review by Dr. Shlipak published in the American Journal of Kidney Disease describes how recent advances in Cystatin C such as standardization should allow Cystatin C to be incorporated further into clinical care for CKD.

http://www.ncbi.nlm.nih.gov/pubmed/23701892